Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TANIA A REYNA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1316143621
CMS profile
195887
Location
TULSA, OK

General Payments · PY2018–2024

$450,866.70

  • Reported across 860 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,123.76

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,435.76 33
Consulting Fee $1,688.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
TG THERAPEUTICS, INC. $1,845.46 2
EMD Serono, Inc. $653.43 8
GENZYME CORPORATION $387.13 4
NOVARTIS PHARMACEUTICALS CORPORATION $328.02 5
Alexion Pharmaceuticals, Inc. $224.28 2
UCB, Inc. $206.59 4
Celgene Corporation $173.43 4
Amgen Inc. $156.30 3
Biogen, Inc. $149.12 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $117,953.71 218
PY2019 $209,377.05 334
PY2020 $50,656.54 133
PY2021 $33,274.94 53
PY2022 $9,024.23 35
PY2023 $26,456.47 53
PY2024 $4,123.76 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $101.29 02/03/2024 Food and Beverage Undisputed 01/23/2026 1094012678 CMS
Alexion Pharmaceuticals, Inc. $122.99 03/28/2024 Food and Beverage Undisputed 01/23/2026 1093967388 CMS
Amgen Inc. $5.73 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116054356 CMS
Amgen Inc. $53.55 09/26/2024 Food and Beverage Undisputed 01/23/2026 1116054364 CMS
Amgen Inc. $97.02 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116054370 CMS
Biogen, Inc. $92.07 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104806389 CMS
Biogen, Inc. $57.05 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104874854 CMS
Celgene Corporation $124.99 01/31/2024 Food and Beverage Undisputed 01/23/2026 1101086083 CMS
Celgene Corporation $17.21 09/17/2024 Food and Beverage Undisputed 01/23/2026 1101086111 CMS
Celgene Corporation $0.86 10/24/2024 Food and Beverage Undisputed 01/23/2026 1101086115 CMS
Celgene Corporation $30.37 10/24/2024 Food and Beverage Undisputed 01/23/2026 1101086117 CMS
EMD Serono, Inc. $129.79 03/06/2024 Food and Beverage Undisputed 01/23/2026 1120231386 CMS
EMD Serono, Inc. $123.44 04/14/2024 Food and Beverage Undisputed 01/23/2026 1120249391 CMS
EMD Serono, Inc. $19.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 1120234668 CMS
EMD Serono, Inc. $99.26 05/20/2024 Food and Beverage Undisputed 01/23/2026 1120245405 CMS
EMD Serono, Inc. $46.99 05/31/2024 Food and Beverage Undisputed 01/23/2026 1120250983 CMS
EMD Serono, Inc. $75.54 05/31/2024 Food and Beverage Undisputed 01/23/2026 1120252198 CMS
EMD Serono, Inc. $59.38 10/07/2024 Food and Beverage Undisputed 01/23/2026 1120277438 CMS
EMD Serono, Inc. $100.03 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120274294 CMS
GENZYME CORPORATION $19.21 02/29/2024 Food and Beverage Undisputed 01/23/2026 1139809775 CMS
GENZYME CORPORATION $149.39 06/05/2024 Food and Beverage Undisputed 01/23/2026 1139809817 CMS
GENZYME CORPORATION $124.99 07/19/2024 Food and Beverage Undisputed 01/23/2026 1139809845 CMS
GENZYME CORPORATION $93.54 11/22/2024 Food and Beverage Undisputed 01/23/2026 1139809907 CMS
Novartis Pharmaceuticals Corporation $55.13 03/01/2024 Food and Beverage Undisputed 01/23/2026 1087284183 CMS
Novartis Pharmaceuticals Corporation $16.66 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087284185 CMS
Novartis Pharmaceuticals Corporation $50.74 04/14/2024 Food and Beverage Undisputed 01/23/2026 1087284187 CMS
Novartis Pharmaceuticals Corporation $78.32 05/29/2024 Food and Beverage Undisputed 01/23/2026 1087284193 CMS
Novartis Pharmaceuticals Corporation $127.17 06/17/2024 Food and Beverage Undisputed 01/23/2026 1087284197 CMS
TG Therapeutics, Inc. $1,688.00 02/28/2024 Consulting Fee Undisputed 01/23/2026 1136889068 CMS
TG Therapeutics, Inc. $157.46 03/26/2024 Food and Beverage Undisputed 01/23/2026 1136889082 CMS
UCB, Inc. $78.60 04/13/2024 Food and Beverage Undisputed 01/23/2026 1143401232 CMS
UCB, Inc. $38.46 04/26/2024 Food and Beverage Undisputed 01/23/2026 1143401236 CMS
UCB, Inc. $1.40 05/02/2024 Food and Beverage Undisputed 01/23/2026 1143401240 CMS
UCB, Inc. $88.13 05/02/2024 Food and Beverage Undisputed 01/23/2026 1143401243 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.